Braun-Bostich & Associates’s Invesco Pharmaceuticals ETF PJP Stock Holding History

Braun-Bostich & Associates’s Portfolio PJP Stock Details PJP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q3	–	Sell	-286	Closed	-$19K	–	315
2020 Q2	$19K	Hold	286	–	–	0.02%	175
2020 Q1	$15K	Hold	286	–	–	0.02%	184
2019 Q4	$19K	Buy	+286	New	+$17.4K	0.02%	200
2019 Q3	–	Sell	-286	Closed	-$17K	–	243
2019 Q2	$17K	Hold	286	–	–	0.02%	241
2019 Q1	$19K	Sell	286 -31	-10%	-$2.04K	0.02%	247
2018 Q4	$20K	Hold	317	–	–	0.02%	228
2018 Q3	$23K	Hold	317	–	–	0.02%	223
2018 Q2	$21K	Hold	317	–	–	0.02%	218
2018 Q1	$20K	Hold	317	–	–	0.02%	217
2017 Q4	$20K	Buy	+317	New	+$20.3K	0.02%	221

Other funds holding PJP

PAM

Peak Asset Management Louisville, Colorado $680M AUM 22.27% 1-Year Est. Return

BCI

Brinker Capital Investments Berwyn, Pennsylvania $13.1B AUM 28.37% 1-Year Est. Return

AWMS

Advocacy Wealth Management Services Atlanta, Georgia $2.75B AUM 19.24% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

LPL Financial San Diego, California $445B AUM 25.58% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Envestnet Asset Management Chicago, Illinois $424B AUM 22.96% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $1.28T AUM 58.89% 1-Year Est. Return

Braun-Bostich & Associates's PJP Position: Q3 2020 in Review

Braun-Bostich & Associates sold out of Invesco Pharmaceuticals ETF (PJP) in Q3 2020, closing a stake of 286 shares — an estimated $19K sold.

Braun-Bostich & Associates first reported a position in PJP in Q4 2017 and held it in 10 quarters. The position peaked at $23K in Q3 2018. 83 funds tracked by Wall St. Rank hold PJP as of Q3 2020.

Braun-Bostich & Associates reported no remaining Invesco Pharmaceuticals ETF position as of Q3 2020 after selling out during the quarter.
Braun-Bostich & Associates sold 286 Invesco Pharmaceuticals ETF shares in Q3 2020, an estimated $19K.
Braun-Bostich & Associates first reported a position in Invesco Pharmaceuticals ETF in Q4 2017 and held it in 10 quarters.
Braun-Bostich & Associates's Invesco Pharmaceuticals ETF position peaked at $23K in Q3 2018.
83 funds tracked by Wall St. Rank held Invesco Pharmaceuticals ETF as of Q3 2020.

Based on Braun-Bostich & Associates's 13F filing for Q3 2020, filed 9 Oct 2020.